[Elsevier] Switch to once-weekly, single-tablet islatravir每lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial |
|
This post will be closed automatically in 2026-09-07 17:40
Reward10points
|
post
reply
points
17950
100
Fracture failure analysis and research on solid expandable tubular with joint thread
10
An update on solid-state form, crystal modification and transition issues related to tablet manufacturing
10
An update on solid-state form, crystal modification and transition issues related to tablet manufacturing
30
Residual Inflammatory Risk of Heart Failure and Atherosclerotic CVD in Diabetes
10
Kinetics study of esterification reaction of acrylic acid with n-butanol
